Studies treating mild to moderate B12 deficiency in older people have failed to provide cognitive benefits: A clinical trial from the Netherlands measured the cognitive response to B12 supplements in people 70 years old with mild B12 deficiency and MMA levels 320 nmol/l (average: ~450 nmol/l)
Analytical testing confirms greater than 99.8 % purity , assay content verified at 55.1 mg and endotoxin levels below 0.001 EU/mg
Another proposed mechanism involves competing interactions at growth factor receptor sites
The efficiency of these products are not intended to diagnose, treat, cure or prevent any disease and are not intended for medical or injectable use
5-Amino-1MQ research tablets for NNMT inhibition studies involving NAD+ salvage, NAM metabolism, SIRT1, PARP, and metabolic signaling pathways
CJC-1295 (also called Mod GRF 1-29) is a GHRH analogue, and Ipamorelin is a highly selective GHRP (ghrelin agonist)